Tumor cell invasion inhibited by TIMP-2.

Area of Science:

• Biochemistry
• Molecular Biology
• Cancer Research

Background:

• Type IV collagenase enzymes are linked to cancer cell invasiveness.
• These enzymes form complexes with tissue inhibitor of metalloproteinases-2 (TIMP-2).
• The balance between collagenase activity and TIMP-2 inhibition is crucial for matrix proteolysis and tumor invasion.

Purpose of the Study:

• To investigate the role of the metalloproteinase-inhibitor balance in human fibrosarcoma HT-1080 cell invasion.
• To determine if altering this balance can inhibit tumor cell invasion of a reconstituted basement membrane.

Main Methods:

• HT-1080 fibrosarcoma cells, which produce 72-kd and 92-kd type IV collagenases, were used.
• The metalloproteinase-inhibitor balance was altered by adding free TIMP-2 or antibodies specific to the 72-kd type IV collagenase.
• Tumor cell invasion through a reconstituted basement membrane was measured.

Main Results:

• Adding excess TIMP-2 blocked HT-1080 cell invasion.
• Antibodies against the 72-kd type IV collagenase also inhibited invasion, demonstrating its critical role.
• The 72-kd type IV collagenase was identified as a key mediator of invasion.

Conclusions:

• Metalloproteinases, particularly the 72-kd type IV collagenase, are essential for tumor cell invasion.
• The endogenous inhibitor TIMP-2 can effectively block this invasion process.
• TIMP-2 shows therapeutic potential for inhibiting tumor cell invasion and intravasation.